Good day, and thank you for standing by. Welcome to Aegon's third quarter 2025 trading update conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you will need to slowly press star one and one on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's conference is being recorded. I would now like to hand the conference over to your speaker, Yves Cormier, Head of Investor Relations. Please go ahead. Thank you, Operator, and good morning, everyone. I would like to welcome you to this call on Aegon's third quarter 2025 trading update. My name is Yves Cormier, Head of Investor Relations. Joining me today to take you through our progress are Aegon CEO Lard Friese and CFO Duncan Russell. Before we start, we would like to ask you to review our disclaimer on forward-looking statements, which you can find at the end of the presentation. With that, I would like to give the floor to Lard. Thank you, Yves, and good morning, everyone. I will start today's presentation by running you through the strategic progress we're making and the commercial performance in the quarter. I will hand over to Duncan, who will address our capital results in more detail. Let me begin on slide number two with the key messages for the quarter. During the third quarter of 2025, we continue to make good progress in transforming our businesses, and we generated EUR 340 million of operating capital generation. World Financial Group expanded its distribution network, adding more licensed agents and increasing their productivity. The commercial momentum in our U.S. strategic assets resulted in higher life and annuity sales. In retirement plans, account balances increased, as did the balance of our ancillary products, and written sales remained strong. In the United Kingdom, we recorded some outflows due to the departure of two large low-margin workplace schemes, while both our asset management and international businesses continued to grow. Turning to our capital position, our units remain well-capitalized. Furthermore, the cash capital at holding remains very healthy at EUR 1.9 billion, despite returning just over EUR 800 million to shareholders in the period. At the end of September, we had executed just over half of our ongoing EUR 400 million share buyback program. We expect to complete the remainder by December 15th. Looking towards the end of the year, we continue to expect to achieve all our financial targets for 2025, despite the weakening of the US dollar during the year. We look forward to providing you with an update on our strategy at our Capital Markets Day on December 10th. On the day, we also aim to share the outcome of a review regarding a potential relocation of our legal domicile and head office to the United States. Let's now move to slide three to discuss the recent commercial performance of the Americas. Our aim is to build Transamerica into America's leading middle-market life insurance and retirement company. In the third quarter, we continue to make good progress with this transformation. At World Financial Group, the number of licensed agents continues to increase steadily, thanks to the successful recruitment of new agents and improved retention of existing agents. The number of multi-ticket agents remains stable compared with the past two quarters, albeit below the level of the third quarter of last year. We have recently focused our actions on improving the productivity of existing agents. This led to a 15% increase in total life sales at WFG and a 9% increase in annuity sales, backed by solid consumer demand. Transamerica's market share in WFG was 65% in the reporting period. Around half of the 39% increase in new life sales in our Protection Solutions segment came from higher index universal life sales at WFG and our own tight agency channel. The remainder of the growth was driven by higher sales of the final expense product we offer through a fully digital underwriting platform that was launched in autumn of 2024. In the Savings & Investments segment, net deposits in our retirement plan business were negative, largely due to outflows in large market plans and slightly negative net deposits in mid-size plans. However, business growth and favorable markets over the last year drove a 10% increase in the total account balances. Written sales in both large market and mid-size plans remained strong, which implies solid levels of takeover deposits for future periods. We generated further growth in both the general accounts stable value product as well as in individual retirement accounts as we work to increase profitability and diversify revenue streams of the retirement plans business. I now move to slide number four to update you on our other businesses. At Aegon U.K., net deposits in the workplace platform were negative for the first time in the last two years. This was due to the departure of two large low-margin schemes. In the advisor platform, we continue to see the adverse impact of ongoing consolidation in the non-target advisor segments. We are working hard to improve the platform experience for our customers, and the enhancements we have delivered to date have been well received, leading to higher net promoter scores. Together with several other initiatives, we aim to return the advisor platform to growth by 2028. In our international segment, we continue to grow our book. Sales in Brazil continue to grow, particularly in credit and group life products, but was largely offset by currency movements. New life sales decreased at our joint venture in China, which offset growth in the other markets. The new life sales contributed to the growth of gross rate and premiums across the book. In asset management, positive third-party net deposits in our global platforms business were mostly driven by inflows in fixed income and alternative fixed income products. In strategic partnerships, net deposits were driven by Aegon's French asset management joint venture with La Banque Postale. With that, I turn to Duncan to discuss our financial performance in more detail. Thank you, Lard. Let me start with slide six. Operating capital generation before holding, funding, and operating expenses increased by 1% year-on-year to EUR 340 million. Free cash flow amounted to EUR 76 million in the period and mainly reflected our share of ASR's 2025 interim dividend. Cash capital at holding remained strong at EUR 1.9 billion, largely from the proceeds of the sale of part of our stake in ASR in September. Gross financial leverage amounted to EUR 4.9 billion, which is consistent with our target level. I now move to slide seven to address operating capital generation, or OCG. Total OCG increased by 1% compared to Q3 2024. OCG from the Americas increased by 6%, or 12% on a constant currency basis. This was driven by a higher contribution from the strategic assets and a broadly stable contribution from the financial assets. The increase of OCG from strategic assets reflected more favorable claims experience compared with the prior year period, as well as a higher release of required capital. This was partially offset by a higher new business strain, largely associated with growth in individual life compared with the third quarter last year. The total new business strain in this quarter remained $10 million below the guidance of around $200 million per quarter. Adjusting for this and $20 million favorable claims experience, the OCG fell within the guidance of $200 million-$240 million per quarter for the U.S. In the U.K., operating capital generation decreased compared with last year when several favorable non-recurring items were recorded, as well as from higher new business strain from a changing product mix. In British pounds, OCG amounted to GBP 38 million, within the current run rate of around GBP 35 million-GBP 40 million per quarter. In the international segment, OCG decreased versus last year, mainly due to lower OCG in China, reflecting the reporting change we implemented at full year 2024. Nevertheless, it was still above the level of around EUR 25 million per quarter, which we see as the run rate, thanks to several favorable non-recurring items this quarter. Asset management OCG increased mostly due to around EUR 6 million of non-recurring items. Stepping back, therefore, we remain on track to achieve our full year OCG target of around EUR 1.2 billion for 2025. On slide eight, we show the capital positions of our main units, which remained robust and above their respective operating levels. The U.S. RBC ratio increased by five percentage points compared with the end of June to 425%. OCG contributed 13 percentage points to the RBC ratio, and this was partially offset by the payment of a dividend from an operating company to our U.S. intermediate holding. This was to pre-finance the planned remittance to the group in the fourth quarter, which had a four percentage points negative impact on the ratio. Market movements had a three percentage points negative impact on the ratio, driven mainly by the interaction of favorable equity markets and flooring on the variable annuity book. One-time items, including management actions, had a two percentage points negative impact on the ratio, largely from restructuring provisions. In the U.K., the solvency ratio of Scottish Equitable increased by three percentage points to 188%, mostly from OCG, while market movements only had a marginal impact on the ratio. I'm now turning to slide nine. Cash capital at holding decreased slightly over the period to EUR 1.9 billion. Free cash flow added EUR 76 million, while the divestiture of 12.5 million shares in ASR in September generated gross proceeds of around EUR 700 million. We continue to expect to deliver free cash flow of around EUR 800 million for the full year, despite the impact of the lower US dollar on remittances from the U.S., with remittances expected from all business units in the fourth quarter. We returned just over EUR 800 million of capital to shareholders in the third quarter. Around EUR 600 million of this was related to the payment of dividends. The remaining amount was returned in the form of a share buyback as part of our ongoing EUR 400 million share buyback program, which we expect to complete by year-end. Finally, capital injections to expand investment management capabilities in our international businesses, as well as some other items, largely related to capital market transaction costs and the ongoing relocation review, reduced the balance by EUR 99 million in total. As mentioned previously, our objective remains to reach the midpoint of the operating range for cash capital at holding, or around EUR 1 billion by the end of 2026. Wrapping up on slide ten, we remain well on track to achieve all of our financial targets for 2025. We look forward to our Capital Markets Day on December the 10th, where we will provide an update on our strategy and financial targets and announce the outcome of our ongoing review regarding a potential relocation to the United States. We invite you to register and join us at the event in London. With that, I would now like to open the call for your questions. Please limit yourself to two questions per person. Operator, please open the Q&A session. Thank you. As a reminder, to ask a question, you will need to slowly press star one and then one on your telephone and wait for your name to be announced. Please be aware that we will take and answer one question at a time before moving to the next question. We will now go to our first question. Your first question today comes from the line of David Barma from Bank of America. Please go ahead. Good morning. Thanks for taking my questions. Firstly, I wanted to ask about your long-term care book. Some of your peers have had to adjust reserves recently to reflect higher incidence levels. I was hoping you could remind us what your assumptions are for incidence versus before COVID and also the mortality and morbidity assumptions you have within that portfolio. I will ask my second question straight away on cash. Your cash conversion of earnings in the U.S. looks like it will still be around 70% for this year. Do you see this level as adequate? What is holding you back from increasing it already? Thank you. Duncan, thank you, David. Good morning. Duncan, over to you. Okay. Good morning, David. On the long-term care, we continue to track quite well, actually, versus our assumptions in the third quarter. You saw that our actual—you can see that our actual to expected claims ratio is 97%. Our PDR, which is a target of ours from the Capital Markets Day, remains at a good level. We continue to make progress on implementing our rate increases with a further $115 million implemented in this quarter. We are making good progress. In terms of our assumptions, we remain happy with our assumptions. We did an assumption review earlier this year, as you recall, where we strengthened our morbidity incidence assumption. We also assumed some higher mortality. That was reflected in our 2Q assumption review overall. In terms of mortality improvement, we think we have a fairly conservative approach in that we assume mortality improvements—we include mortality improvements for off-claim lives but exclude it for on-claim lives. We think that is pretty conservative. Finally, on morbidity improvements, if you recall, we removed an assumption around morbidity improvement back in the second quarter of 2023, which we think is in line with industry best practice. Overall, we are very happy with our assumptions, and we are seeing continued good progress on our long-term care book. Your second question was cash conversions. Cash conversions. I assume what you are referring to there is the ratio of remittances coming out of the U.S. to either our first operating earnings or our OCG. Just to remind you, we target a stable progression of remittances out of our business units. Back at the Capital Markets Day in 2023 in the U.S., we were targeting a mid-single-digit growth out of our U.S. business in terms of remittances. That remains our go-forward assumption. In terms of the overall level of cash conversions, remember, we have OCG, but we're also making investments in the businesses below the line, which impacts total capital generation. Thank you. Thank you. We will now go to the next question. Your next question comes from the line of Iain Pearce from BNP Paribas. Please go ahead. Hi. Yeah, morning, everyone. My first question was just on the strategic assets in the U.S. When I look at the year-on-year sort of Q3 versus Q3 last year, the eligible own funds generation seems to be down across all three of the units. Just wondering if you could elaborate on what's driving that lower own funds generation when we just look at that line rather than the sort of OCG as a whole. The second one was just on the reduction in capital employed in the financial assets. Obviously, that's come down quite nicely in Q3. Just wondering if you could talk about what the driver of that reduction is and if that sort of run rate is a good run rate or if there's something special in Q3 that drives that bigger move. Thank you. Yeah. Thank you very much, Ian. Duncan, can you say anything in this session? Yeah. Funds generation from strategic assets and then the reduction of capital employed in financial assets and the underlying drivers for that. Maybe on the capital employed in financial assets, which I think is fairly easy. Indeed, we're seeing good progress on reduction in the capital employed in financial assets, which has continued to fall over the last couple of years and indeed also in the third quarter. If you recall, we implemented our base fee hedge in the third quarter, which helped to reduce required capital for the variable annuity book. In addition, favorable equity markets and the interaction between that and flooring also contributed to a reduction in required capital. Basically, our required capital for variable annuities has continued to drop in the third quarter. That basically explains the reduction in financial assets overall. Your second question, I'm not entirely sure what it was actually, but I think is it referring to earnings on in-force? Yeah. Yeah. If I look at the first slide of the appendix, slide 13, year-on-year, if you look at the earnings on in-force for the distribution, savings & investments, and Protection Solutions business, those lines are all down Q3 2025 versus Q3 2024. I am just wondering what is driving that because obviously the OCGs are, but it seems to be predominantly by release of capital and lowering new business strain movements, I suppose. Yeah. Okay. No, I understand now. Thank you. Sorry for that. Thank you. On distribution, as I mentioned in my speaker notes, we've had some margin pressure on the distribution business. That's because we are making some investments into our franchise there in order to ensure that the medium to long-term prospects remain buoyant. We had a bit of margin pressure on the distribution side. On the other products, savings and investments are just fairly lumpy. In any one quarter, we can get puts and takes and nothing material driving that. On protection, earnings on in-force is down because of just movements in mortality compared to the prior year. Okay. Okay. Thank you. Thank you. Your next question today comes from the line of Nasib Ahmed from UBS. Please go ahead. Hi. Morning. Thanks for taking my question. First one, I guess for Duncan, stranded costs in the financial assets, can you give us kind of some sense of what kind of costs you're allocating to the financial assets? The reason I ask is because I think back in the day when you were looking at the variable annuity book, that was one of the points that you needed to take into account in terms of offloading that business. Second one, I guess a follow-up to David's initial question on payout ratio. I think in the 2020 CMD pack, you had a 75% payout ratio for the group. I know you had the Netherlands in there. The medium-term target to improve that from 75% to a higher level. Is that kind of still what we should be expecting in terms of payout to OCG? Thank you. Yeah. On the second one, again, just to reiterate, how we're managing the cash flows into the holding is we're trying to make sure that the units, A, pay remittances in line with the growth in their cash flow. For the U.S., for example, we've guided towards a mid-single-digit growth in the remittances coming out. B, we do not want that number to jump up and down year-on-year too much because we like predictability in the cash flow coming to the holding. It allows us to plan and to manage the use of cash. C, and I think that's what you're referring to, the capital markets data, over time as the quality of our businesses improve, given that we have been a bit of a restructuring story. Therefore, the quality of our earnings improve, then over time, there should be potential to increase the payout ratio over time. Your other question was stranded costs. I cannot give you a precise number right now. I will come back to that maybe at the Capital Markets Day. Indeed, when we consider actions around our financial assets, we have a range of considerations around that. One of the inputs indeed is stranded costs because they do represent a sizable portion of our balance sheet, as you know. Therefore, they do cover an element of fixed costs. Let us come back to you, potentially at the Capital Markets Day, with a bit more guidance on how we think on that. Thank you. So far, by the way, our actual to expected performance on costs on the financial assets has been good. Thank you. As a reminder, to ask a question, you will need to slowly press star one and one on your telephone and wait for your name to be announced. We will now take the next question. The next question is a follow-up from David Barma from Bank of America. Please go ahead. Thanks for taking my follow-up. On variable annuities, Duncan, you previously mentioned the possibility of fixing the flooring via internal reinsurance through a captive, I think. Is this still on the table, or are you okay keeping that non-economic sensitivity in the VA block? Secondly, on the net flows into the U.S. mid-market retirement plans, they have been very, very volatile in the last years, but only slightly positive on average. Lars, would you be able to give us some color on the competitive dynamics there and what the more elevated withdrawal rates might be driven by? Lastly, coming back to mortality and morbidity and widening the question from just the long-term care block to the whole U.S. business. If I got this right, I think eight of the last ten quarters were more favorable than expected. Could you talk about the dynamics there and at what point you'd recognize this as a structural trend versus where your reserving and expectations are? Thank you. Yeah. David, on the retirement plans in the U.S., frankly, as I mentioned in my speaker notes, the business in total is developing actually quite well and has reached now $251 billion of AUA, of which the AUA for mid-sized plans has increased to $62 billion. The written sales, which is a good indicator for future takeover deposits, are actually strong, and they remain strong. If you look at the net deposits cumulatively over the last four to eight quarters, we have booked net deposits of $1.4 billion in the last four quarters and $2.2 billion in the last eight quarters, respectively, in dollars. You see really that the underlying business is really strengthening quite a bit. Actually, in our view, we are progressing quite well in the business. As I said, the written sales remain strong for both large and mid-markets. Pipeline is strong. We believe that we're actually pretty well positioned here. On the sensitivity, we provided, again, the RBC sensitivities in our presentation. What you see from those is that our sensitivity to equity markets on a statutory basis for ± 10% is pretty manageable. A 25% drop has roughly 24 percentage points hit to the RBC. I think we are in quite a good position there. Indeed, we have this peculiarity whereby if equity markets go up 25%, which is obviously a very good thing for our business and our long-term earnings power, our RBC would fall by, as of the third quarter, roughly 52 percentage points. That is entirely due to the flooring, which, as you pointed out, is non-economic. At this point in time, we have not taken any action on the flooring. It is something which we will continue to monitor. If we feel that that becomes a constraint or an issue for us, we will indeed explore potential options to mitigate that. So far, we felt that that's not something we needed to do. We did implement a base hedge, as you recall, last quarter to dampen our underlying economic sensitivities to equity markets. That remains in place as of today. The second question was life mortality. I do not know if it is precisely right in terms of your statistic on the number of quarters, but indeed, the thing we do monitor every quarter in detail, the amount of mortality actual to expected. Since we made the assumption updates a period ago on mortality, we have had, I would say, fairly neutral overall outcomes, mortality coming in more or less with what we would have expected, which is a good thing. In any one quarter, that can be a positive or minus. This quarter, it was a positive. Overall, it's giving us comfort that our mortality assumptions are in the right sort of area. Thank you. Thank you. Thank you. We'll take the next question. The question comes from the line of Jason Kalamboussis from ING. Please go ahead. Yes. Hi. Good morning. Thank you for taking my questions. The first one is for Lars. If you can give us the same comments that you gave on the U.S., that means how you see on the U.K. the developments this year or back end of last year and this year compared to your plans? Are you satisfied with it? The second question is on the U.S.-RBC ratio. In fourth quarter, clearly, it is more likely to be lower. I would be interested to understand if it is a level you are happy with or if we should be looking at some stage for some injection from the holding into the U.S. Also, just mentioning that, I mean, I do not follow the U.S. life insurance industry, but my impression was that a lot of your peers like to be in the 430%-440% level. If you can comment on that, it would be much appreciated. Thank you very much. Yeah. Let me take the first question, Jason. Good morning on the U.K. And then Duncan will discuss the RBC topic. On the U.K., as you know, we have announced our plans for the U.K. to turn it into a leading savings and pension player in the U.K. We have also disclosed how we would do that in the coming years. We have set targets. We want to get the advisor platform to net positive by 2028 and the overall platform to grow in total by GBP 5 billion by 2028. We have also set other targets associated with it and also investments that we would make to the, especially the advisor platform, to make the customer journeys more intuitive. We are doing that against the backdrop of a market in the advisor platform business where we see a lot of vertical consolidation happening. That is driving part of the reason for the outflows there. The other piece was that we felt that the platform needed work and needed improvements and a lot of new releases and capabilities. That is why we are doing quite some investments in it. On the workplace side, you have seen now two years of very strong workplace business. The fact that we now have two, this quarter, two plans that are going out, which are low margin, by the way, should not detract from the reality, which is that this is a very strong business that has structurally provided either a number two or a number three position in attracting new plans. That business is doing well, and one quarter does not change that. When it comes to the advisor platform, we continue to roll out new releases and improvements. That actually leads to a positive reception. We have seen that in our net promoter scores. That is number one. You know that we target 500 advisors. The feedback we are getting from them is also positive. This is a more longer-term trajectory, as we said, because we want to turn it to positive by the end of 2028. We are on track. It is not an easy turnaround story that we have there. The workplace business, strong business, advisor platform, doing what we expected it to do, reception of the improvements that we are making is positive, is good. As a result, we maintain our targets for 2028 for the business. Duncan, RBC. On the RBC, I think you're aware, we have what we call an operating level, which is our kind of normal level. We would target for the business of around 400%. We have a minimum dividend payment level of 350%, which is the level at which we would continue to pay remittances up from the U.S. into the holding. We're currently slightly above that. From my perspective, that's fine. U.S. peers are anywhere between 350%-450%, depending on business mix, how they're structured as an organization, etc. I do not think we're an outlier, to be honest. From my perspective, the RBC ratio is at a fine level. Thank you very much. Thank you. Your next question comes from the line of Michele Ballatore from KBW. Please go ahead. Yes. Thank you for taking my question. Sorry if I missed this, but the reduction of around $200 million in the capital employed in the financial asset versus the second quarter, I mean, is there any particular action taken there? If you can maybe give me some details about this. Also, on the target of reaching $2.2 billion, should we expect more details around these particular factors at the next Capital Markets Day? Thank you. It's Duncan here. I already mentioned that if you recall in the second quarter week, or just after the second quarter, I think August, mid-August, we implemented a base fee hedge on a portion of the base fees. That obviously reduced required capital because we're reducing our risk exposure. In addition, what I mentioned to you is that as equity markets moved up, there's an interaction with how the flooring works, which reduced required capital with some offset in reserves. The combination of those two things meant that the amount of required capital in variable annuities fell in the quarter. That basically explained the whole movement in financial assets in 3Q. I think the second question was in terms of the target for 2027. We continue to make progress, as you saw, as you've seen, actually. We've made good progress in reducing it since we originally came out with the designation of financial assets. We made good progress during this year as well from a combination of management actions, unilateral and bilateral. We're going to continue to explore all options on the financial assets, actions we can take ourselves, actions we can take with our customers. If the economics are right, third-party actions with external counterparties. Thank you. Thank you. The next question comes from the line of David Barma from Bank of America. Please go ahead. Sorry, it's me again. Just one last small follow-up on the capital employed again. There's a lot of different moving parts in tracking this capital employed figure between what you're doing, the equity performance, the run-off of the book, etc. Duncan, could you give us a sense of how you're doing compared with the ambition for a $700 million reduction coming from management actions? The management action part specifically of the reduction in the capital employed, please. Thank you. Yeah. I agree with you, by the way. There are a lot of moving parts. When I look at the financial assets in general, to be honest, the overriding principle is how we're managing the risk profile. Capital employed is one way of expressing that. As you can see and as you know, there are many moving parts and drivers of that. I also look at the sensitivities, particularly under an IFRS basis where you do not have the impacts of floorings, etc. I think your point is fair. In terms of management actions, I think we have made reasonable progress. By management actions, I mean including things like optimizing the hedging strategy, right? The implementation of the base fee hedge. I think we have made reasonable progress. Some of the management actions we anticipated years ago we would implement did not work out. That is because markets behaved differently than we thought. This book is quite sensitive to markets. We identified other actions we could take, including the base fee hedge, which I will set that. We have made reasonable progress. I think as we look forward to delivering the target, it is likely we are going to have to have further management actions. The natural run-off of the book is not going to be sufficient. We will continue to look for actions we can take in our own control and, as I keep pointing out, potential third-party transactions if they make sense economically. Overall, though, David, I think we are doing okay versus our target in aggregate. Things move around. We block and tackle. We adjust our own plans depending on what is happening with markets and where our levels are. Overall, I think we are in a pretty good place of managing the financial assets down. Okay. Thank you. Thank you. Your next question comes from the line of Michael Huttner from Berenberg. Please go ahead. Hi there. I'm really sorry. I joined the call late, so it probably will be answered, but just in case. I have two. The one is on the cash, and the other one is on mortality. On cash, can you give us a feel for the walk forward from the $1.8 billion and change in nine months and the $1 billion target you've kind of set for 2026? What could be the potential moving parts? The other one is on mortality exposure. From memory, I think you reduced maybe 30%, even 40%, the institutionally owned lives. That is gone now. Can you give us a feel for what the current mortality exposure is at the group level and how you think of it as developing? I noticed mortality was $12 million better in Q3, which to me feels like a low number. I would have expected around 30. Maybe there's some moving parts I'm not aware of. Thank you. Thank you, Michael. Yeah, it's a busy day today for disclosures. So Duncan. On the cash, Michael, you're basically asking us to give you a movement from here to the target of $1 billion by the end of 2026, which we're not going to do, at least not today. As you know, the cash capital in the holding, we are going to bring down to $1 billion by the end of 2026. We have three broad buckets which we can deliver that. The first is to deleverage further with our current portfolio, which is not required in any meaningful way. The second is to fund either organic or inorganic initiatives, which our businesses may source or the group may source. The final one is if neither of those emerge, we'll return the capital to shareholders as we have been doing over the prior quarters. We aim to do all this by the end of 2026, so just over a year from now, not too much longer to wait. In terms of mortality, I think you're right, firstly, in our strategy and mitigating mortality risk. We had a program to purchase institutionally owned policies, which we successfully executed upon. Also, we've done, I think, two reinsurance transactions on our legacy life books in the U.S. in the past. We updated our assumptions, obviously, which, as I pointed out in a prior question, are trending more or less as we would expect since that assumption update. Things look okay. In our statistical supplement, we give you under the financial assets KPIs, we give you the net face amount for universal life, which I think is a reasonable number to track in terms of our total exposure on this book, hopefully answering what you were asking. How much was the institutional purchase so far? Is it all now gone clear through the capital? I think there's an element where you have to cancel the stuff before the re- and you have to wait for the reinsurers to agree. Sorry. Not all of it has been canceled. I think, because as you're aware, the process is we purchase the policies from the institutional owner. All of these policies have reinsurance on them, and we negotiate with the reinsurers for them to take their share of the exposure. If we were to cancel fully our remaining exposure as of today, there would be a negative impact on the RBC ratio of around 11 percentage points, including the release of the equity, which is in that vehicle. Brilliant. Just the last figure, how much have you bought back of the institutional to date? As of 3 Q, we've bought back. We reached our target. We were targeting through a call to purchase 40% of the outstanding face value of around $7 billion. We hit that target in 3 Q 2024. Our activity since then has been more muted. Brilliant. Thank you. Thank you very much, indeed. Lovely. Thank you. We have no further questions. I would like to hand the call back over to Yves Cormier for closing remarks. Thank you, Operator. This concludes our Q&A session. Should you have any remaining questions, please get in touch with the investor relations team. On behalf of Lard and Duncan, I would like to thank you for your attention. Thanks again, and have a good day. Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.